• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1.

作者信息

Härterich Steffen, Koschatzky Susanne, Einsiedel Jürgen, Gmeiner Peter

机构信息

Department of Chemistry and Pharmacy, Emil Fischer Center, Friedrich Alexander University, Schuhstrasse 19, D-91056 Erlangen, Germany.

出版信息

Bioorg Med Chem. 2008 Oct 15;16(20):9359-68. doi: 10.1016/j.bmc.2008.08.051. Epub 2008 Aug 27.

DOI:10.1016/j.bmc.2008.08.051
PMID:18809332
Abstract

Investigating prototypical interactions between NT(8-13) and the human neurotensin receptor 1 (hNTR1), we created a receptor-ligand model that was validated by site-directed mutagenesis and structure-activity relationship studies. Stabilization of the extracellular loop 1 (EL1) by pi-stacking clusters proved to be important for agonist binding when substitution of six conserved amino acids by alanine resulted in an agonist specific loss of maximal binding capacity. In agreement with our modeling studies, EL1 seems to adopt a clamp-type border area controlling the shape of the binding site crevice. Employing chemically manipulated peptide analogs as molecular probes, the impact of backbone modifications on receptor-ligand interaction, especially the influence on ligand conformation, was examined in binding studies and explained by in silico analysis.

摘要

相似文献

1
Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1.
Bioorg Med Chem. 2008 Oct 15;16(20):9359-68. doi: 10.1016/j.bmc.2008.08.051. Epub 2008 Aug 27.
2
Peptide backbone modifications on the C-terminal hexapeptide of neurotensin.神经降压素C端六肽的肽主链修饰
Bioorg Med Chem Lett. 2008 Mar 15;18(6):2013-8. doi: 10.1016/j.bmcl.2008.01.110. Epub 2008 Feb 2.
3
Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.髓鞘碱性蛋白富含脯氨酸区域与SH3结构域的结合:配体构象及翻译后修饰效应的光谱学、微阵列和建模研究
Biochemistry. 2008 Jan 8;47(1):267-82. doi: 10.1021/bi701336n. Epub 2007 Dec 8.
4
Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.人源肝脏受体同源物-1的分子动力学模拟:配体结合对组成型活性核受体的影响
Biochemistry. 2008 May 6;47(18):5205-15. doi: 10.1021/bi7025084. Epub 2008 Apr 15.
5
Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.过敏毒素C5a与C5a受体结合的分子机制建模。
Biochemistry. 2008 Mar 11;47(10):3117-30. doi: 10.1021/bi702321a. Epub 2008 Feb 15.
6
Functional domains of the subtype 1 neurotensin receptor (NTS1).1型神经降压素受体(NTS1)的功能结构域。
Peptides. 2006 Oct;27(10):2461-8. doi: 10.1016/j.peptides.2006.02.013. Epub 2006 Aug 9.
7
The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.小鼠5-HT3A受体的环C区域促成了5-羟色胺和间氯苯双胍的不同作用。
Biochemistry. 2005 Jun 28;44(25):9140-9. doi: 10.1021/bi050661e.
8
Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modeling.通过定点诱变和分子建模确定缓激肽受体B1与激肽相互作用的关键残基。
Biochemistry. 2006 Dec 5;45(48):14355-61. doi: 10.1021/bi060673f.
9
Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13).神经降压素(8-13)跨膜受体的拟议配体结合位点。
J Biol Chem. 1996 Jun 21;271(25):15060-8. doi: 10.1074/jbc.271.25.15060.
10
Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.神经降压素与人类神经降压素 1 型受体第三细胞外环之间的分子间相互作用。
J Biomol Struct Dyn. 2013 Dec;31(12):1381-92. doi: 10.1080/07391102.2012.736776. Epub 2012 Nov 12.

引用本文的文献

1
Development of a Neurotensin-Derived Ga-Labeled PET Ligand with High In Vivo Stability for Imaging of NTS Receptor-Expressing Tumors.开发一种具有高体内稳定性的神经降压素衍生的镓标记PET配体,用于成像表达NTS受体的肿瘤。
Cancers (Basel). 2022 Oct 8;14(19):4922. doi: 10.3390/cancers14194922.
2
Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS Receptor Affinity.精氨酸和异亮氨酸位点的修饰赋予神经降压素(8 - 13)衍生物高稳定性并保留对神经降压素受体的亲和力。
ACS Med Chem Lett. 2019 May 10;10(6):960-965. doi: 10.1021/acsmedchemlett.9b00122. eCollection 2019 Jun 13.
3
Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
基于结构的 NTS1 受体变构结合口袋研究:使用双位 NT(8-13)衍生物和分子动力学模拟。
J Mol Model. 2019 Jun 17;25(7):193. doi: 10.1007/s00894-019-4064-x.
4
In Search of the Optimal Macrocyclization Site for Neurotensin.寻找神经降压素的最佳大环化位点。
ACS Med Chem Lett. 2018 Jan 29;9(3):227-232. doi: 10.1021/acsmedchemlett.7b00500. eCollection 2018 Mar 8.
5
Modeling of the OX1R-orexin-A complex suggests two alternative binding modes.OX1R-食欲素-A复合物的模型表明存在两种替代结合模式。
BMC Struct Biol. 2015 May 9;15:9. doi: 10.1186/s12900-015-0036-2.
6
Synthesis of a (68)ga-labeled peptoid-Peptide hybrid for imaging of neurotensin receptor expression in vivo.用于体内神经降压素受体表达成像的(68)镓标记类肽-肽杂合物的合成。
ACS Med Chem Lett. 2010 May 21;1(5):224-8. doi: 10.1021/ml1000728. eCollection 2010 Aug 12.
7
In vivo monitoring of the antiangiogenic effect of neurotensin receptor-mediated radiotherapy by small-animal positron emission tomography: a pilot study.小动物正电子发射断层扫描监测神经降压素受体介导的放射治疗的抗血管生成作用:一项初步研究。
Pharmaceuticals (Basel). 2014 Apr 16;7(4):464-81. doi: 10.3390/ph7040464.
8
The activity of prolactin releasing peptide correlates with its helicity.催乳素释放肽的活性与其螺旋度相关。
Biopolymers. 2013 May;99(5):314-25. doi: 10.1002/bip.22162.
9
Structure of the agonist-bound neurotensin receptor.激动剂结合神经降压素受体的结构。
Nature. 2012 Oct 25;490(7421):508-13. doi: 10.1038/nature11558. Epub 2012 Oct 10.
10
Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics.多巴胺 D2L 受体和神经降压素 NTS1 受体之间的交叉受体相互作用调节多巴胺能药物的结合亲和力。
ACS Chem Neurosci. 2011 Jun 15;2(6):308-16. doi: 10.1021/cn200020y. Epub 2011 Apr 11.